https://orcid.org/0000-0001-5816-6220
References
- Xiang F, He M, Morgan IG, et al. The impact of parental myopia on myopia in Chinese children: population-based evidence. Optom Vis Sci. 2012;89(10):1487–1496. doi:https://doi.org/10.1097/OPX.0b013e31826912e0.
- Morgan IG, Ohno-Matsui K, Saw SM, et al. Myopia. Lancet. 2012;379:1739–1748. doi:https://doi.org/10.1016/S0140-6736(12)60272-4.
- ,Chen Z, Huangd S, Zhou J, et al. Adjunctive effect of orthokeratology and low dose atropine on axial elongation in fast-progressing myopic children—A preliminary retrospective study.
- Hiraoka T, Kakita T, Okamoto F, et al. Longterm effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study. Invest Ophthalmol Vis Sci. 2012;53:3913–3919. doi:https://doi.org/10.1167/iovs.11-8453.
- Sherwin JC, Reacher MH, Keogh RH, et al. The association between time spent outdoors and myopia in children and adolescents: a systematic review and meta-analysis. Ophthalmology. 2012;119:2141–2151. doi:https://doi.org/10.1016/j.ophtha.2012.04.020.
- Huang J, Wen D, Wang Q, et al. Efficacy comparison of 16 interventions for myopia control in children: a network metaanalysis. Ophthalmology. 2016;123:697–708. doi:https://doi.org/10.1016/j.ophtha.2015.11.010.
- Gallego P, Martinez-Garcia C, Perez-Merino P, et al. Scleral changes induced by atropine in chicks as an experimental model of myopia. Ophthalmic Physiol Opt. 2012;32(6):478–484. doi:https://doi.org/10.1111/j.1475-1313.2012.00940.x.
- Lin Z, Vasudevan B, Liang YB, et al. Near work induced transient myopia (NITM) in anisometropia. Ophthalmic Physiol Opt. 2013;33:311–317. doi:https://doi.org/10.1111/opo.12049.
- Li FF, Kam KW, Zhang Y, et al. Effects on ocular biometrics by 0.05%, 0.025%, and 0.01% atropine: low-concentration atropine for myopia progression (LAMP) study. Ophthalmology. 2020;10:1016.
- Yam JC, Jiang Y, Tang SM, et al. Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, and 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology. 2019;126(1):113–124. doi:https://doi.org/10.1016/j.ophtha.2018.05.029.
- Nichols JJ, Marsich MM, Nguyen M, et al. Bullimore, overnight orthokeratology. Optom Vis Sci. 2000;77(5):252–259. doi:https://doi.org/10.1097/00006324-200005000-00012.
- Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53:7077–7085. doi:https://doi.org/10.1167/iovs.12-10565.
- Cho P, Cheung SW, Edwards M. The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res. 2005;30:71–80. doi:https://doi.org/10.1080/02713680590907256.
- Chia A, Chua WH, Wen L, et al. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol. 2014;157:451–457.e1. doi:https://doi.org/10.1016/j.ajo.2013.09.020.
- Fan DS, Lam DS, Chan CK, et al. Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: A pilot study. Jpn J Ophthalmol. 2007;51:27–33. doi:https://doi.org/10.1007/s10384-006-0380-7.
- Kastelan S, Lukenda A, Salopek-Ｒabati, et al. Dry eye symptoms and signs in longterm contact lens wearers. Coll Antropol. 2013;37(1):199203.
- D H S, Iskander DR. Tear film dynamics on soft contact lenses. Optom Vis Sci. 2014;91:14061411.